Metadata
Title ddAC→T: Dose-Dense Doxorubicin/Cyclophosphamide then Paclitaxel — Breast Cancer
Version 0.1.1-snapshot-080926
Experimental true
Subject Type Malignant neoplasm of breast
Jurisdiction United States of America
Steward (Publisher) HL7 International / Clinical Interoperability Council
Steward Contact HL7 International / Clinical Interoperability Council
Description

Dose-dense AC x4 cycles (q14d) with pegfilgrastim support, followed by paclitaxel x4 cycles (q14d) for breast cancer.
Type Order Set
PlanDefinition Action
Id ac-phase
Title AC Phase — Doxorubicin + Cyclophosphamide (q14d × 4 cycles)
Timing Count 4 times, Once per 14 days
PlanDefinition Sub-Action (Parent Action ID: ac-phase)
Id doxorubicin-ac
Title Doxorubicin 60 mg/m² IV — Day 1 of each 14-day cycle
Timing Once per 14 days
PlanDefinition Sub-Action
Id doxorubicin-ac
Title Doxorubicin 60 mg/m² IV — Day 1 of each 14-day cycle
Timing Once per 14 days
PlanDefinition Sub-Action (Parent Action ID: ac-phase)
Id pegfilgrastim-ac
Title Pegfilgrastim 6 mg subcutaneous — Day 2 of each 14-day cycle
Description Pegfilgrastim supportive care on day 2 of each ddAC cycle
Timing Once per 14 days
PlanDefinition Sub-Action
Id pegfilgrastim-ac
Title Pegfilgrastim 6 mg subcutaneous — Day 2 of each 14-day cycle
Description Pegfilgrastim supportive care on day 2 of each ddAC cycle
Timing Once per 14 days
PlanDefinition Sub-Action (Parent Action ID: ac-phase)
Id cyclophosphamide-ac
Title Cyclophosphamide 600 mg/m² IV — Day 1 of each 14-day cycle
Timing Once per 14 days
PlanDefinition Sub-Action
Id cyclophosphamide-ac
Title Cyclophosphamide 600 mg/m² IV — Day 1 of each 14-day cycle
Timing Once per 14 days
PlanDefinition Action
Id t-phase
Title T Phase — Paclitaxel (q14d × 4 cycles)
Timing Count 4 times, Once per 14 days
PlanDefinition Sub-Action (Parent Action ID: t-phase)
Id paclitaxel-t
Title Paclitaxel 175 mg/m² IV — Day 1 of each 14-day cycle
Timing Once per 14 days
PlanDefinition Sub-Action
Id paclitaxel-t
Title Paclitaxel 175 mg/m² IV — Day 1 of each 14-day cycle
Timing Once per 14 days
Generated using version 0.5.4 of the sample-content-ig Liquid templates
<type> <coding> <system value="http://terminology.hl7.org/CodeSystem/plan-definition-type"/> <code value="order-set"/> <display value="Order Set"/> </coding> </type> <status value="active"/> <experimental value="true"/> <subjectCodeableConcept> <coding> <system value="http://snomed.info/sct"/> <code value="254837009"/> <display value="Malignant neoplasm of breast"/> </coding> </subjectCodeableConcept> <date value="2026-09-08T18:17:28-04:00"/> <publisher value="HL7 International / Clinical Interoperability Council"/> <contact> <name value="HL7 International / Clinical Interoperability Council"/> <telecom> <system value="url"/> <value value="http://www.hl7.org/Special/committees/cic"/> </telecom> <telecom> <system value="email"/> <value value="ciclist@lists.HL7.org"/> </telecom> </contact> <description value="Dose-dense AC x4 cycles (q14d) with pegfilgrastim support, followed by paclitaxel x4 cycles (q14d) for breast cancer."/> <jurisdiction> <coding> <system value="urn:iso:std:iso:3166"/> <code value="US"/> <display value="United States of America"/> </coding> </jurisdiction> <action id="ac-phase"> <title value="AC Phase — Doxorubicin + Cyclophosphamide (q14d × 4 cycles)"/> <timingTiming> <repeat> <count value="4"/> <period value="14"/> <periodUnit value="d"/> </repeat> </timingTiming> <action id="doxorubicin-ac"> <title value="Doxorubicin 60 mg/m² IV — Day 1 of each 14-day cycle"/> <timingTiming> <repeat> <period value="14"/> <periodUnit value="d"/> </repeat> </timingTiming> </action> <action id="pegfilgrastim-ac"> <title value="Pegfilgrastim 6 mg subcutaneous — Day 2 of each 14-day cycle"/> <description value="Pegfilgrastim supportive care on day 2 of each ddAC cycle"/> <timingTiming> <extension url="http://hl7.org/fhir/us/codex-mopa/StructureDefinition/regimen-days-of-cycle"> <extension url="day"> <valueInteger value="2"/> </extension> </extension> <repeat> <period value="14"/> <periodUnit value="d"/> </repeat> </timingTiming> </action> <action id="cyclophosphamide-ac"> <title value="Cyclophosphamide 600 mg/m² IV — Day 1 of each 14-day cycle"/> <timingTiming> <repeat> <period value="14"/> <periodUnit value="d"/> </repeat> </timingTiming> </action> </action> <action id="t-phase"> <title value="T Phase — Paclitaxel (q14d × 4 cycles)"/> <relatedAction> <actionId value="ac-phase"/> <relationship value="after-end"/> </relatedAction> <timingTiming> <repeat> <count value="4"/> <period value="14"/> <periodUnit value="d"/> </repeat> </timingTiming> <action id="paclitaxel-t"> <title value="Paclitaxel 175 mg/m² IV — Day 1 of each 14-day cycle"/> <timingTiming> <repeat> <period value="14"/> <periodUnit value="d"/> </repeat> </timingTiming> </action> </action> </PlanDefinition>